These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 29063295)
1. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy. Shida D; Tsukamoto S; Ochiai H; Kanemitsu Y Ann Surg Oncol; 2018 Jan; 25(1):173-178. PubMed ID: 29063295 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer. Jeon Y; Park EJ; Lim JH; Baik SH World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O; Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis. Shida D; Yoshida T; Tanabe T; Tsukamoto S; Ochiai H; Kanemitsu Y Ann Surg Oncol; 2018 Jun; 25(6):1646-1653. PubMed ID: 29572704 [TBL] [Abstract][Full Text] [Related]
5. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129 [TBL] [Abstract][Full Text] [Related]
6. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6). Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ; BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center. Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148 [TBL] [Abstract][Full Text] [Related]
8. Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis. Sato H; Maeda K; Kotake K; Sugihara K; Takahashi H J Gastroenterol; 2016 May; 51(5):465-72. PubMed ID: 26377391 [TBL] [Abstract][Full Text] [Related]
9. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study. Goéré D; Glehen O; Quenet F; Guilloit JM; Bereder JM; Lorimier G; Thibaudeau E; Ghouti L; Pinto A; Tuech JJ; Kianmanesh R; Carretier M; Marchal F; Arvieux C; Brigand C; Meeus P; Rat P; Durand-Fontanier S; Mariani P; Lakkis Z; Loi V; Pirro N; Sabbagh C; Texier M; Elias D; Lancet Oncol; 2020 Sep; 21(9):1147-1154. PubMed ID: 32717180 [TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan. Kitaguchi D; Park EJ; Baik SH; Sasaki S; Tsukada Y; Ito M Int J Surg; 2024 Jan; 110(1):45-52. PubMed ID: 37800569 [TBL] [Abstract][Full Text] [Related]
11. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983 [TBL] [Abstract][Full Text] [Related]
13. Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change. Bhandare M; Patil P; Pai V; Bhamre R; Engineer R; Ostwal V; Saklani A Clin Colorectal Cancer; 2017 Jun; 16(2):e1-e6. PubMed ID: 27670895 [TBL] [Abstract][Full Text] [Related]
14. Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC. Wong EYT; Tan GHC; Ng DWJ; Koh TPT; Kumar M; Teo MCC J Gastrointest Cancer; 2017 Dec; 48(4):353-360. PubMed ID: 27864747 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis. Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I; Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy. Zhou S; Jiang Y; Liang J; Pei W; Zhou Z World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125 [TBL] [Abstract][Full Text] [Related]
17. The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis. Repullo DJ; Barbois S; Leonard D; Bohlok A; Van den Audenaeren ET; Hendlisz A; Van den Eynde M; Donckier V; Kartheuser A; Liberale G Eur J Surg Oncol; 2021 Jul; 47(7):1661-1667. PubMed ID: 33602530 [TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center. Huang CQ; Yang XJ; Yu Y; Wu HT; Liu Y; Yonemura Y; Li Y PLoS One; 2014; 9(9):e108509. PubMed ID: 25259574 [TBL] [Abstract][Full Text] [Related]
19. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis. Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615 [TBL] [Abstract][Full Text] [Related]
20. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]